Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Novo Nordisk ( (NVO) ) just unveiled an update.
Novo Nordisk A/S has disclosed information in its Annual Report for the year ended December 31, 2024, in compliance with the Iran Threat Reduction and Syria Human Rights Act of 2012 and the Securities Exchange Act of 1934. This filing, made on February 5, 2025, signifies the company’s adherence to regulatory requirements, potentially influencing its operations and stakeholder perceptions.
More about Novo Nordisk
YTD Price Performance: -5.60%
Average Trading Volume: 7,983,463
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $370.2B
Learn more about NVO stock on TipRanks’ Stock Analysis page.
